Morphine and Jadenu drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Morphine (morphine sulfate) and Jadenu (deferasirox). Common drug interactions include nausea among females and pancreatitis among males.
The phase IV clinical study analyzes what interactions people have when they take Morphine and Jadenu. It is created by eHealthMe based on reports of 64 people who take the same drugs from the FDA, and is updated regularly.
What is Morphine?
Morphine has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 182,914 Morphine users. Check the latest studies of Morphine.
What is Jadenu?
Jadenu has active ingredients of deferasirox. eHealthMe is studying from 4,176 Jadenu users. Check the latest studies of Jadenu.
64 people who take Morphine and Jadenu together, and have interactions are studied.

What are the common drug interactions of Morphine and Jadenu, by gender? *:
female:
- Nausea (feeling of having an urge to vomit)
- Abdominal pain upper
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Diarrhoea
- Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Hospitalisation
- Thrombocytopenia (decrease of platelets in blood)
- Vomiting
- Coma (state of unconsciousness lasting more than six hours)
male:
- Pancreatitis (inflammation of pancreas)
- Haemoglobin decreased
- Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
- Neck pain
- Oxygen saturation decreased
- Pyrexia (fever)
- Diarrhoea
- Dyspnoea (difficult or laboured respiration)
- Hospitalisation
- Infected skin ulcer
What are the common drug interactions of Morphine and Jadenu, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Coma (state of unconsciousness lasting more than six hours)
- Febrile convulsion (a convulsion associated with a significant rise in body temperature)
- Hepatitis (inflammation of the liver)
- Acute chest syndrome (acute chest pain, fever and difficulty breathing)
- Acute hepatic failure
- Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
- Cerebral haemorrhage (bleeding within the brain)
- Chest pain
- Coagulopathy (blood's ability to clot is impaired)
- Encephalopathy (functioning of the brain is affected by some agent or condition)
20-29:
- Pancreatitis (inflammation of pancreas)
- Throat irritation
- Fatigue (feeling of tiredness)
- Pneumonia
- Abdominal pain upper
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Diarrhoea
- Headache (pain in head)
- Hospitalisation
- Hyperhidrosis (abnormally increased sweating)
30-39:
- Dyspnoea (difficult or laboured respiration)
- Chest pain
- Hospitalisation
- Acute respiratory failure
- Cough
- Device dislocation
- General physical health deterioration (weak health status)
- Haemoglobin decreased
- Nausea (feeling of having an urge to vomit)
- Thrombosis (formation of a blood clot inside a blood vessel)
40-49:
- Nausea (feeling of having an urge to vomit)
- Vomiting
50-59:
- Hypoxia (low oxygen in tissues)
- Liver disorder (liver diseases)
- Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
- Dysgeusia (disorder of the sense of taste)
- Nausea (feeling of having an urge to vomit)
- Pharmacophobia (fear of the use of pharmacological treatments)
- Shoulder operation
- Vomiting
60+:
- Asthenia (weakness)
- Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
- Pneumonia
- Tremor (trembling or shaking movements in one or more parts of your body)
- Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Thrombocytopenia (decrease of platelets in blood)
- Infection
- Nerve compression
- Abdominal pain upper
What are the existing conditions these people have? *
- Iron Overload: 12 people, 18.75%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 6.25%
* Approximation only. Some reports may have incomplete information.
Do you take Morphine and Jadenu?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Morphine and Jadenu:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Morphine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Jadenu:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Morphine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Jadenu and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
- Díaz-García JD, Gallegos-Villalobos A, Gonzalez-Espinoza L, Sanchez-Ni?o MD, Villarrubia J, Ortiz A, "Deferasirox nephrotoxicity [mdash] the knowns and unknowns", Nature reviews nephrology, 2014 Oct .
- Riva A, "Comment on: A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Expert opinion on drug safety, 2013 Sep .
- Riva A, "Deferasirox's toxicity", The Lancet, 2013 Jul .
- Kontoghiorghes GJ, "Turning a blind eye to deferasirox's toxicity?", The Lancet, 2013 Apr .
- Kontoghiorghes GJ, "A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Taylor & Francis, 2013 Jan .
- Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
- Díaz-García JD, Gallegos-Villalobos A, Gonzalez-Espinoza L, Sanchez-Ni?o MD, Villarrubia J, Ortiz A, "Deferasirox nephrotoxicity [mdash] the knowns and unknowns", Nature reviews nephrology, 2014 Oct .
- Riva A, "Comment on: A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Expert opinion on drug safety, 2013 Sep .
- Riva A, "Deferasirox's toxicity", The Lancet, 2013 Jul .
- Kontoghiorghes GJ, "Turning a blind eye to deferasirox's toxicity?", The Lancet, 2013 Apr .
- Kontoghiorghes GJ, "A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Taylor & Francis, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on morphine sulfate and deferasirox (the active ingredients of Morphine and Jadenu, respectively), and Morphine and Jadenu (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Novolin N and Budesonide - 9 seconds ago
- Drug interactions of Maprotiline Hydrochloride and Furosemide - 10 seconds ago
- Bone Marrow Disorder and drugs of ingredients of rituximab - 17 seconds ago
- Could Mirena cause Flatulence? - 21 seconds ago
- Drug interactions of Amoxicillin And Clavulanate Potassium and Tamoxifen Citrate - 27 seconds ago
- Could Megestrol Acetate cause Speech Disorder? - 34 seconds ago
- Could Depakote cause Periodontal Disease? - 36 seconds ago
- Could Motrin cause Genital Haemorrhage? - 44 seconds ago
- Could Telmisartan cause Metastases To Lung? - 49 seconds ago
- Methotrexate and Hydrocortisone Sodium Succinate drug interactions for girls aged 10-19 - 58 seconds ago